Author:
Rogers S.L,Doody R.S,Pratt R.D,Ieni J.R
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference26 articles.
1. Diagnostic and Statistical Manual of Mental Disorders,1994
2. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention;Berg;Ann. Neurol.,1992
3. Cognitive decline in Alzheimer’s disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination;Brooks;Int. Psychogeriatrics,1993
4. Burns, A., Rossor, M., Hecker, J., Gauthier, S., Petit, H., Möller, H.J., Rogers, S.L., Friedhoff, L.T., The International Donepezil Study Group, 1999. The effects of donepezil in Alzheimer’s disease-results from a multinational trial. Dement. Geriat. Cog. Dis. 10, 237–244.
5. Corey-Bloom, J., Anand, R., Veach, J., ENA 713 B352 Study Group, 1998. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new cholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease. Int. J. Geriatr. Psychopharmacol. 1, 55–65.
Cited by
221 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献